Seizures Can Occur Due To Stun Guns A new case report published in CMAJ indicates that stun guns, under particular conditions, may cause cerebral complications such as seizures. http://www.cmaj.ca/press/pg625.pdf. The investigation of an incident involving a police officer suggests that seizures may happen and should be considered as an undesirable consequence of the use of these devices.
Source: www.medicalnewstoday.comStudy Looks At Celebrex And Lipitor To Treat Prostate Cancer The
FDA-approved drugs Celebrex® and Lipitor® used respectively for arthritis pain and lowering one's cholesterol, are being tested by investigators at The Cancer Institute of New Jersey (CINJ) to see if they hold any promise in slowing or stopping the growth of prostate cancer when combined. CINJ is a center of excellence of UMDNJ-Robert Wood Johnson Medical School.
Source: www.medicalnewstoday.comSome Cancer Drugs Can Encourage Tumour Growth UK scientists found that a type of angiogenesis inhibitor used to treat cancer can actually encourage rather than stop tumour growth when given at low doses.
Source: www.medicalnewstoday.comGlobal HIV-Related TB Deaths Higher Than Previously Thought A new report from the World Health Organization shows that while the total number of new TB cases worldwide remained stable in 2007, and the proportion of people becoming ill with TB continued to fall, the proportion of TB deaths that are HIV related is now thought to be 25 per cent, which is twice as many as previously estimated.
Source: www.medicalnewstoday.comMerck Serono Statement Regarding Media Coverage Today On Pre-clinical Integrin Inhibitor Study In Animal Model In a preclinical study published in Nature Medicine, findings from mouse models investigating integrin inhibitors in selected tumor types showed that continuous exposure to very low concentrations of our investigational drug cilengitide may increase tumor growth. These data diverge from previous findings in numerous other preclinical models of cilengitide in vitro or in vivo.
Source: www.medicalnewstoday.comAutomatic Slicing System: Ex-vivo Culture Normal And Cancerous Pancreatic Tissue Pancreatic cancer is a devastating disease with a very poor prognosis. This warrants the development of novel therapies including gene therapy. Several of these treatments were found to be effective in pre-clinical (animal) models. However, in the subsequent clinical studies in patients the results were disappointing. The discrepancy between pre-clinical models and results seen in patients underscores the need for pre-clinical models that more reliable predict the clinical efficacy.
Source: www.medicalnewstoday.comFDA Approves New Indication For Wyeth's TYGACIL (tigecycline) For The Treatment Of Adult Patients With Community Acquired Bacterial Pneumonia Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced that the U.S. Food and Drug Administration (
FDA) approved TYGACIL(R) (tigecycline), for the treatment of adult patients with community-acquired bacterial pneumonia (CABP) caused by susceptible strains of indicated pathogens.
Source: www.medicalnewstoday.comInsufficient Vitamin D Levels In Americans A report in the March 23 issue of Archives of Internal Medicine (a journal from JAMA/Archives) indicates that in the United States from 1994 to 2004, the average blood levels of vitamin D seem to have decreased. In the past, the most important health conditions linked to vitamin D deficiency were poor bone mineral content in adults and rickets in children.
Source: www.medicalnewstoday.comDiscovery Of Cellular Process That Fights Type 1 Herpes Simplex A report on the online edition of Nature Immunology informs that our immune system has a new means to fight off the virus of Type 1 herpes simplex (HSV-1). Scientists from the Université de Montréal, in a teamwork effort with American colleagues, have discovered a cellular process to identify and fight herpes.
Source: www.medicalnewstoday.com
# posted by Network @ 1:11 PM
